$RKLB Balance Sheet | Understand Stock

$RKLB

$58.34 +$0.03 (0.05%) After hours

$RKLB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Marketable securities, current
Accounts receivable, net
Contract assets
Inventories
Prepaids and other current assets
Assets held for sale
Total current assets
Non-current assets:
Property, plant and equipment, net
Intangible assets, net
Goodwill
Right-of-use assets - operating leases
Right-of-use assets - finance leases
Marketable securities, non-current
Restricted cash
Deferred income tax assets, net
Other non-current assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Trade payables
Accrued expenses
Employee benefits payable
Contract liabilities
Current installments of long-term borrowings
Other current liabilities
Total current liabilities
Non-current liabilities:
Convertible senior notes, net
Long-term borrowings, net
Non-current operating lease liabilities
Non-current finance lease liabilities
Deferred income tax liabilities
Public and private warrant liabilities
Other non-current liabilities

Total liabilities
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively
Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 639,131,688 and 589,525,802 at June 30, 2026 and December 31, 2025, respectively; outstanding shares: 598,180,438 and 543,574,552 at June 30, 2026 and December 31, 2025, respectively
Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, shares issued (in shares)
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Series E preferred stock
Series E 1 preferred stock
Series E 1 preferred stock
Total preferred stock, shares issued (in shares)

Preferred stock, shares outstanding (in shares)
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Series E preferred stock
Series E 1 preferred stock
Series E 1 preferred stock
Total preferred stock, shares outstanding (in shares)

Treasury stock shares (in shares)

Comments